Abiopharma

Palisade Bio Announces Strategic Equity Investment from the Crohns & Colitis Foundations IBD Ventures Program to Advance PALI-2108

Evaxion Biotech A/S (EVAX) Files Form 6-K

Palisade Bio Announces Strategic Equity Investment from the Crohn’s & Colitis Foundation’s IBD Ventures Program to Advance PALI-2108

SeaStar Medical Announces 2026 Milestones

ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus

Purple Biotech Ltd. (PPBT) Files Form 6-K

(99% Neutral) 4D Molecular Therapeutics, Inc. (FDMT) Reports Q4 2025 Financial Results

Natera - Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer

Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference

Inspire Medical Systems, Inc. - Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026

ENLIVEX (ENLV) Files Form 6-K

Alterity Therapeutics Limited (ATHE) Files Form 6-K

Johnson & Johnson - Johnson & Johnson SubmitsOTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product